ABBA-19

N/A

Report date: 2025/01/26 15:58:36

Base Information

Drug NameABBA-19
Drug Alias Namehumanized antibody (ABBA Therapeutics)ABBA-19
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesABBA Therapeutics AG
China Registration ClassN/A

Develop Information

Active CompaniesABBA Therapeutics AG
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsHead and Neck NeoplasmsSarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A